Therapeutic angiogenesis by autologous-peripheral blood mononuclear cells (A-PBMNC) implantation has been shown to be a safe and effective treatment for critical limb ischemia (CLI). We herein report our investigation of the long-term efficacy of implantation of A-PBMNC produced by selective filtration to treat patients with CLI, for which surgical bypass and/or percutaneous transluminal angioplasty are not possible
Objective. Critical limb ischemia (CLI) is the most dangerous stage of peripheral artery disease (PA...
Critical limb ischemia (CLI) constitutes the most severe form of peripheral arterial disease (PAD), ...
Critical limb ischemia (CLI) is the advanced stage of peripheral artery disease spectrum and is defi...
Therapeutic angiogenesis by autologous-peripheral blood mononuclear cells (A-PBMNC) implantation has...
INTRODUCTION: Critical Limb Ischemia (CLI) patients have a poor prognosis despite they are submitted...
Background—Injection of bone marrow mononuclear cells has been reported to promote neovascularizatio...
Background: Stem cell therapy has been proposed to enhance the salvage of critically ischemic limbs....
When in critical limb ischemia (CLI) the healing process aborts or does not follow an orderly and ti...
Abstract Background: Cell therapy with autologous peripheral blood mononuclear cells (PB-MNCs) may h...
Critical limb ischemia (CLI) constitutes the most severe form of peripheral arterial disease (PAD), ...
BackgroundThis study investigated the efficacy and safety of autologous bone marrow-mononuclear cell...
Peripheral arterial disease is a common but under-recognized problem. As the disease progresses, the...
Prognosis of peripheral artery disease (PAD), especially critical limb ischemia, is very poor despit...
ObjectiveThe purpose of this Phase I open label nonrandomized trial was to assess the safety and eff...
BackgroundThis study investigated the feasibility, safety, and efficacy of the intramuscular injecti...
Objective. Critical limb ischemia (CLI) is the most dangerous stage of peripheral artery disease (PA...
Critical limb ischemia (CLI) constitutes the most severe form of peripheral arterial disease (PAD), ...
Critical limb ischemia (CLI) is the advanced stage of peripheral artery disease spectrum and is defi...
Therapeutic angiogenesis by autologous-peripheral blood mononuclear cells (A-PBMNC) implantation has...
INTRODUCTION: Critical Limb Ischemia (CLI) patients have a poor prognosis despite they are submitted...
Background—Injection of bone marrow mononuclear cells has been reported to promote neovascularizatio...
Background: Stem cell therapy has been proposed to enhance the salvage of critically ischemic limbs....
When in critical limb ischemia (CLI) the healing process aborts or does not follow an orderly and ti...
Abstract Background: Cell therapy with autologous peripheral blood mononuclear cells (PB-MNCs) may h...
Critical limb ischemia (CLI) constitutes the most severe form of peripheral arterial disease (PAD), ...
BackgroundThis study investigated the efficacy and safety of autologous bone marrow-mononuclear cell...
Peripheral arterial disease is a common but under-recognized problem. As the disease progresses, the...
Prognosis of peripheral artery disease (PAD), especially critical limb ischemia, is very poor despit...
ObjectiveThe purpose of this Phase I open label nonrandomized trial was to assess the safety and eff...
BackgroundThis study investigated the feasibility, safety, and efficacy of the intramuscular injecti...
Objective. Critical limb ischemia (CLI) is the most dangerous stage of peripheral artery disease (PA...
Critical limb ischemia (CLI) constitutes the most severe form of peripheral arterial disease (PAD), ...
Critical limb ischemia (CLI) is the advanced stage of peripheral artery disease spectrum and is defi...